XML 208 R113.htm IDEA: XBRL DOCUMENT v3.25.0.1
NET LOSS PER SHARE - Schedule of Antidilutive Securities (Details) - shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Net potential dilutive outstanding securities (in shares) 45,150,140 33,991,696 29,032,947
Share options      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Net potential dilutive outstanding securities (in shares) 3,740,789 3,895,087 6,379,785
Options to restricted shares      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Net potential dilutive outstanding securities (in shares) 19,948,408 20,046,080 20,217,940
RSUs      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Net potential dilutive outstanding securities (in shares) 3,009,918 3,034,203 479,497
Ordinary share warrants | Ordinary share warrants      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Net potential dilutive outstanding securities (in shares) 2,016,321 2,016,326 1,955,725
Redeemable convertible preferred shares      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Net potential dilutive outstanding securities (in shares) 5,000,000 5,000,000 0
Exchangeable notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Net potential dilutive outstanding securities (in shares) 11,434,704 0 0